晚发性不明原因癫痫患者中阿尔茨海默病理、睡眠与认知的关联
本研究前瞻性纳入85例晚发性不明原因癫痫(LOUE)患者,探讨血浆p-tau217与认知及睡眠微结构的关系。发现较高的血浆p-tau217与较差的认知(PACC5)相关,且难治性癫痫加重此关联;p-tau217升高与纺锤波-慢波耦合减少相关,约24%的p-tau217与认知的关联由纺锤波-慢波耦合介导。
要点
- LOUE患者中血浆p-tau217升高与认知功能较差独立相关。
- 难治性癫痫与高p-tau217共存时认知损害更显著。
- 纺锤波-慢波耦合部分介导p-tau217与认知的关联。
核心结论
- 在LOUE患者中,血浆p-tau217升高与认知损害和睡眠微结构破坏相关,难治性癫痫患者认知缺陷最明显。
研究设计与样本
- 前瞻性队列研究,纳入85例LOUE患者(平均年龄71.3±7.1岁,49%女性),进行认知测试(PACC5)和24小时脑电图睡眠评分。
主要发现
- 血浆log-p-tau217每增加1单位,PACC5 β=-0.66(95%CI -1.19至-0.13,p=0.0017)。
- 难治性癫痫与p-tau217交互项β=-1.49(95%CI -2.94至-0.05,p=0.04)。
- p-tau217升高与纺锤波-慢波耦合减少相关。
- 纺锤波-慢波耦合介导约24%的p-tau217与认知关联(95%CI 3%-85%,p=0.032)。
临床怎么用
- 血浆p-tau217可作为LOUE患者认知损害的潜在生物标志物。
- 对LOUE患者应关注睡眠微结构,尤其难治性癫痫患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Late-onset unexplained epilepsy (LOUE) has been linked to accelerated cognitive decline. However, the role of neurodegenerative proteins and whether they exert their effects through sleep-related mechanisms remain unexplored in this population. The goal of this study was to investigate the association of plasma p-tau217, a measure of Alzheimer disease (AD) pathology, with cognition in LOUE and its association with sleep. METHODS: Participants with LOUE, with new-onset unprovoked seizures, age at onset 55 years or older, and absence of cortical lesions on MRI, were prospectively recruited. They underwent cognitive testing which included the extended Preclinical Alzheimer Cognitive Composite (PACC5). A 24-hour EEG was obtained, and sleep manually scored. Measures of sleep macroarchitecture and N2/N3 microarchitecture were extracted including slow oscillation (SO), fast spindle (FS), slow spindle (SS), and spindle-SO coupling measures. RESULTS: Eighty-five participants enrolled (mean age 71.3 ± 7.1 years; 49% female). The average PACC5 Z score (±SD) was -0.63 ± 1.0. Higher plasma levels of log-transformed p-tau217 (per 1 unit increase) were associated with poorer cognition, PACC5 (β = -0.66; 95% CI -1.19 to -0.13; p = 0.0017), after adjusting for age, sex, and education. The severity of epilepsy modulated this relationship: individuals with both elevated p-tau217 and medication-refractory epilepsy exhibited worse cognitive performance (refractory epilepsy * p-tau217 interaction term β = -1.49; 95% CI -2.94 to -0.05; p = 0.04). Higher plasma p-tau217 levels were associated with reduced spindle-SO coupling. Mediation analysis indicated that approximately 24% of the association between p-tau217 and cognition was accounted for by spindle-SO coupling (95% CI 3%-85%, p = 0.032). DISCUSSION: In individuals with LOUE, elevated plasma p-tau217 was associated with both cognitive impairment and disrupted sleep microarchitecture, with the most pronounced cognitive deficits observed in individuals with medication refractory epilepsy. These findings support the utility of plasma p-tau217 as a biomarker in this population and underscore the role of sleep processes in the relationship between neurodegenerative pathology and cognition in older adults with epilepsy.
引用
- Sarkis RA, Yang HS, Liu L, et al. Association Between Alzheimer Pathology, Sleep, and Cognition in Patients With Late-Onset Unexplained Epilepsy. Neurology. 2026. PMID: 42673553. doi:10.1212/WNL.0000000000218476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。